# Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma

> **NCT05141513** · PHASE1 · RECRUITING · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 25 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **RADIATION:** High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)

## Key facts

- **NCT ID:** NCT05141513
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-06
- **Primary completion:** 2026-07
- **Final completion:** 2028-04
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141513, "Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05141513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*